Severe hyperkalemia as a complication of timolol, a topically applied beta-adrenergic antagonist.
Severe hyperkalemia occurred in a patient with radiation pneumonitis and glaucoma shortly after beginning prednisone therapy. There was no evidence of renal failure, diabetes, acidosis, increased potassium intake, or significant tissue trauma. Medications having adverse effects on potassium metabolism were considered, and the patient's use of timolol maleate eyedrops was discontinued. His serum potassium level normalized despite continuation of the prednisone therapy. He became hyperkalemic on rechallenge with timolol and normokalemic following its withdrawal. This case indicates that the potential for beta-blocker-induced hyperkalemia exists even with topical appreciation.
D000368:Aged; D002908:Chronic Disease; D005901:Glaucoma / Q000150:complications / Q000188:drug therapy; D006801:Humans; D006947:Hyperkalemia / Q000097:blood / Q000139:chemically induced*; D008297:Male; D009883:Ophthalmic Solutions; D011014:Pneumonia / Q000150:complications / Q000188:drug therapy; D011188:Potassium / Q000097:blood; D011241:Prednisone / Q000627:therapeutic use; D011832:Radiation Injuries / Q000150:complications / Q000188:drug therapy; D013999:Timolol / Q000009:adverse effects*
D009883:Ophthalmic Solutions; D013999:Timolol; D011188:Potassium; D011241:Prednisone